  |
 | Up a level |
Finn, Richard S. and Boer, Katalin and Bondarenko, Igor and Patel, Ravindranath and Pinter, Tamas and Schmidt, Marcus and Shparyk, Yaroslav V. and Thummala, Anu and Voitko, Nataliia and Bananis, Eustratios and McRoy, Lynn and Wilner, Keith and Huang, Xin and Kim, Sindy and Slamon, Dennis J. and Ettl, Johannes (2020) Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first‑line treatment of ER+/HER2− advanced breast cancer (PALOMA‑1, TRIO‑18). Breast Cancer Research and Treatment, 183. pp. 419-428. ISSN 0167-6806 (print); 1573-7217 (online)
Finn, Richard S. and Crown, John and Lang, Istvan and Boer, Katalin and Bondarenko, Igor and Kulyk, Sergey O. and Ettl, Johannes and Patel, Ravindranath and Pinter, Tamas and Schmidt, Marcus and Shparyk, Yaroslav V. and Thummala, Anu and Voytko, Nataliya L. and Fowst, Camilla and Huang, Xin and Kim, Sindy and Slamon, Dennis J. (2017) Overall survival results from the randomized phase II study of palbociclib (P) in combination with letrozole (L) vs letrozole alone for frontline treatment of ER+/HER2–advanced breast cancer (PALOMA-1; TRIO-18). Journal of Clinical Oncology, 35 (15). p. 1001. ISSN 0732-183X (Print) ; 1527-7755 (Electronic) ; 0732-183X (Linking)
Finn, Richard S. and Crown, John P. and Ettl, Johannes and Bondarenko, Igor M. and Lang, Istvan and Pinter, Tamas and Boer, Katalin and Patel, Ravindranath and Randolph, Sophia and Kim, Sindy T. and Huang, Xin and Schnell, Patrick and Nadanaciva, Sashi and Bartlett, Cynthia Huang and Slamon, Dennis J. (2016) Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18. Breast Cancer Research, 18 (67). pp. 1-14. ISSN 1465-542X
